Results 121 to 130 of about 4,733 (164)

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. [PDF]

Lancet
GBD 2021 Diseases and Injuries Collaborators.
europepmc   +1 more source

Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. [PDF]

Lancet Neurol
GBD 2021 Nervous System Disorders Collaborators.
europepmc   +1 more source

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Public Health
GBD 2021 Tobacco Forecasting Collaborators.
europepmc   +1 more source

Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. [PDF]

Lancet
Global Nutrition Target Collaborators.
europepmc   +1 more source

Islamic Finance: Aims, Claims and the Realities of the Market Place [PDF]

, 2012
Visser, H.
core   +2 more sources

A causality investigation into stock prices and macroeconomic indicators in the Indian stock market. [PDF]

F1000Res
Singh Chauhan S, Suri P, Alam F, Hani U, Johri A, Ali F.   +5 more
europepmc   +1 more source

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. [PDF]

Lancet
GBD 2021 Global Stillbirths Collaborators.
europepmc   +1 more source

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.

Lancet, 2020
HALT-IT Trial Collaborators.
europepmc   +1 more source

Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Public Health
GBD Epilepsy Collaborators.
europepmc   +1 more source

Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. [PDF]

Eye (Lond)
Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators.   +1 more
europepmc   +1 more source